A Randomized Placebo-Controlled Phase III Study of Duloxetine for Treatment of Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Women with Early Stage Breast Cancer.
Cancer - Breast,
D’Amour Center for Cancer Care
3350 Main Street, Springfield MA 01199
The purpose of this study is to assess the effects, good and/or bad, of the medication duloxetine compared to placebo (contains no active ingredient) on your joint pain that is associated with taking aromatase inhibitors.
Candidates must be post-menopausal and must currently be taking one of the following aromatase inhibitor. Patients requiring antidepressants for management of depression are not appropriate candidates for this placebo-controlled study
Rae Lynn Defeo